Clinical Research Directory
Browse clinical research sites, groups, and studies.
CTNNA1 Familial Expansion Study
Sponsor: Abramson Cancer Center at Penn Medicine
Summary
The goal of the CAFÉ Study is to determine the cancer risks associated with germline CTNNA1 loss-of-function variants.
Official title: CTNNA1 Familial Expansion (CAFÉ) Study
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
100
Start Date
2021-03-16
Completion Date
2028-01-01
Last Updated
2026-02-05
Healthy Volunteers
No
Interventions
Collection of personal and family history from CAFÉ Study participants
Personal medical and genetic history, as well as relevant information about family history, will be collected from participants in the CAFÉ Study through an online data entry system
Locations (1)
Abramson Cancer Center of the University of Pennsylvania
Philadelphia, Pennsylvania, United States